AlphaCrest Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,391
| Closed | -$1.42M | – | 144 |
|
|
2022
Q3 | $1.42M | Buy |
3,391
+2,693
| +386% | +$1.12M | 0.09% | 397 |
|
|
2022
Q2 | $346K | Sell |
698
-1,511
| -68% | -$749K | 0.02% | 1067 |
|
|
2022
Q1 | $1.24M | Sell |
2,209
-487
| -18% | -$274K | 0.07% | 447 |
|
|
2021
Q4 | $2.04M | Buy |
2,696
+2,408
| +836% | +$1.82M | 0.08% | 420 |
|
|
2021
Q3 | $215K | Sell |
288
-534
| -65% | -$399K | 0.01% | 1202 |
|
|
2021
Q2 | $530K | Sell |
822
-1,212
| -60% | -$781K | 0.02% | 940 |
|
|
2021
Q1 | $1.16M | Buy |
2,034
+193
| +10% | +$110K | 0.06% | 433 |
|
|
2020
Q4 | $1.07M | Buy |
+1,841
| New | +$1.07M | 0.09% | 297 |
|
|
2020
Q3 | – | Sell |
-574
| Closed | -$259K | – | 1090 |
|
|
2020
Q2 | $259K | Sell |
574
-904
| -61% | -$408K | 0.04% | 699 |
|
|
2020
Q1 | $518K | Sell |
1,478
-410
| -22% | -$144K | 0.06% | 552 |
|
|
2019
Q4 | $699K | Buy |
1,888
+388
| +26% | +$144K | 0.06% | 564 |
|
|
2019
Q3 | $499K | Sell |
1,500
-610
| -29% | -$203K | 0.03% | 913 |
|
|
2019
Q2 | $660K | Buy |
+2,110
| New | +$660K | 0.06% | 587 |
|
|
2019
Q1 | – | Sell |
-1,600
| Closed | -$372K | – | 820 |
|
|
2018
Q4 | $372K | Buy |
+1,600
| New | +$372K | 0.11% | 357 |
|